🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Quick review article of last week's #VascularAnomalies #VASCA Working Group 2-day #online meeting now available here: vascern.eu/review-of-the-… Great job to all! #ERNeu Miikka. Vikkula @leoschultzekool Laurence Boon C. van der Vleuten hėctor fabio vásquez Veronika Dvorakova CMTC-OVM VASCAPA_asbl Paolo Gasparella

Miikka. Vikkula and Laurence Boon are one of the top researchers on vascular anomalies in the world and we are very grateful for they participation on our interdisciplinary monthly meeting ! VASCERN #vascularanomalies grupodeanomaliasvasculares

Join us in giving Tia Teiniketo a HUGE CONGRATULATIONS for being named the 2019-20 Conference USA Most Improved Golfer! She also earned Second Team All-Conference USA for finishing the year with a school record 72.9 stroke average‼️👏⛳️ 🔗: bit.ly/CUSAMostImprov…

Exciting news! Our team members Laurence Boon and Miikka. Vikkula have a new publication! Read more 👇#research #science #vascularanomalies

3 new #patient pathways, #capillary, #venous and #lymphatic #malformation, produced by the #vascular #anomalies #VASCA WG, now available vascern.eu/capillary-veno… #ERNeu Miikka. Vikkula @leoschultzekool Laurence Boon @HevasNederland eulalia baselga C. van der Vleuten Nader Ghaffarpour

For those interested in #Vascular anomalies, here the final link to our review on current knowledge and ideas on future therapies.#vascapa #radiorg #vacure #deduveinstitute link.springer.com/article/10.100…

6 new #subtitles added to the #KlippelTrenaunay syndrome #KTS #PoK video: #Dutch, #French, #German, #Italian, #Spanish and #Swedish! Share and raise awareness for this #raredisease : vascern.eu/six-new-langua… #ERNeu #vascularmalformation @HevasNederland VASCAPA_asbl CMTC-OVM LGD Alliance Europe

New ✨#VASCERNspotlights✨article with Dr. Andrea Diociaiuti, #dermatologist from Bambino Gesù #Italy and member of the #VascularAnomalies #VASCA WG! Talks #patientpathways, #raredisease #research, hopes for #ERNeu + more! Read his #interview here: vascern.eu/vascern-spotli…

A novel gene involved in lymphedema, ident. by Miikka. Vikkula &co. Published in Science Translational Medicine, this is essential for diagnosis of patients. It opens a novel pathway for new treatments. #Lymphedema is a strongly invalidating chronic disease, affecting over 1M people in Europe.

Des chercheurs de l'UCLouvain identifient un gène responsable de la maladie des "jambes gonflées" dlvr.it/RgHY9c

One more step forward to precise diagnostics and identification of targets for development of innovative therapies #vascapa #radiorg #vacure #le&rn

Just realized Miikka. Vikkula and colleagues de Duve Institute @UCLouvain_be and University of Helsinki make the cover of Science Translational Medicine with their paper on #lymphedema. well done :)

@Welbio_asbl de Duve Institute @UCLouvain_be University of Helsinki Science Translational Medicine Isn’t this am impressive view. The ANGPT2 ligand in yellow binding two different TIE2 receptor molecules (blue and green) in the complex. We need more molecular level imaging to better comprehend function and dysfunction.

Researchers discovered a novel gene involved in primary lymphedema | University of Helsinki helsinki.fi/en/news/health…

New article about how 2 patients from #Serbia + #Portugal have benefited from the #expertise of the #VascularAnomalies WG, without leaving their respective countries, thanks to the Clinical #Patient Management System (#CPMS): vascern.eu/two-external-g… #ERNeu #eHealth #ShareCareCure

A study of 543 patients reveals mutations in the #ANGPT2 protein that contribute to primary #lymphedema, a discovery that sheds more light on the genetic origins of this incurable condition. HiLIFE_Helsinki Miikka. Vikkula Veli-Matti Leppänen fcld.ly/lgwcbal Credit: Leppänen et al.

A great new step on our path towards better treatments for #vascular #anomalies #vacure #vascapa #radiorg #vascern

Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome. dlvr.it/Rkz4XM

To make progress, we have to stop treating our opponents as enemies. We are not enemies.